Deep sequencing of B cell receptor repertoires from COVID-19 patients reveals strong convergent immune signatures
20 May 2020 – Alchemab’s publication illustrating progress in understanding patients’ immune responses to COVID19 which will help inform vaccination and antibody therapeutics.